Carolyn Dundes came to Stanford Medicine to learn about brain development and stem cell biology, not to be a spokesperson for gender minorities.
Carolyn Dundes came to Stanford Medicine to learn about brain development and stem cell biology, not to be a spokesperson for gender minorities.
Image caption Caroline Wyatt visited Prof Robin Franklin to find out more about a drug that might help stop the progression of MS "I don't like to think of the future. It's such a big question mark
DUBLIN--(BUSINESS WIRE)--The "3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. The 3D bioprinting market is projected to reach USD 1,647 million by 2024 from USD 651 million in 2019, at a CAGR of 20.4% from 2019 to 2024. The growth in this market is mainly driven by technological advancements in 3D bioprinters and biomaterials, increasing the use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities
Cell culture is a complex procedure in which cells are grown under controlled physical conditions outside the natural environment. These cells are used to develop model systems for research, study of cellular structure and functions, stem cell research, drug discovery and genetic engineering.
The Progress 1000 is compiled every year.
Recent Comments